[ad_1] (HealthDay) – A de-escalation of tritherapy to indacaterol / glycopyrronium may lead to a slight reduction in lung function in non-exacerbating patients frequently with chronic obstructive pulmonary disease (COPD), but no …
Read More »Small reduction in lung function with dexcitation of Tx in COPD
